Advertisement

B cells from patients with chronic GVHD are activated and primed for survival via BAFF-mediated pathways

Jessica L. Allen, Matthew S. Fore, Jenna Wooten, Philip A. Roehrs, Nazmim S. Bhuiya, Todd Hoffert, Andrew Sharf, Allison M. Deal, Paul Armistead, James Coghill, Don A. Gabriel, Robert Irons, Amber Essenmacher, Thomas C. Shea, Kristy Richards, Corey Cutler, Jerome Ritz, Jonathan Serody, Albert S. Baldwin and Stefanie Sarantopoulos

Article Information

Citation 
vol. 120 no. 12 2529-2536
PubMed 

Print ISSN 
Online ISSN 
History 
  • Submitted June 22, 2012
  • Accepted July 29, 2012
  • Published online September 20, 2012.

Article Versions


Contributors 
  • Jessica L. Allen, 1University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC;
  • Matthew S. Fore, 1University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC;
  • Jenna Wooten, 1University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC;
  • Philip A. Roehrs, 2Division of Pediatric Hematology-Oncology, University of North Carolina School of Medicine, Chapel Hill, NC; 3Division of Hematology-Oncology, Bone Marrow and Stem Cell Transplant Program, University of North Carolina School of Medicine, Chapel Hill, NC;
  • Nazmim S. Bhuiya, 4Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, MA;
  • Todd Hoffert, 5Hematolymphoid Disorder Tissue Procurement Facility, University of North Carolina School of Medicine, Chapel Hill, NC;
  • Andrew Sharf, 3Division of Hematology-Oncology, Bone Marrow and Stem Cell Transplant Program, University of North Carolina School of Medicine, Chapel Hill, NC;
  • Allison M. Deal, 1University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC; 6Biostatistics and Clinical Data Management Core, University of North Carolina, Chapel Hill, NC; and
  • Paul Armistead, 3Division of Hematology-Oncology, Bone Marrow and Stem Cell Transplant Program, University of North Carolina School of Medicine, Chapel Hill, NC;
  • James Coghill, 3Division of Hematology-Oncology, Bone Marrow and Stem Cell Transplant Program, University of North Carolina School of Medicine, Chapel Hill, NC;
  • Don A. Gabriel, 3Division of Hematology-Oncology, Bone Marrow and Stem Cell Transplant Program, University of North Carolina School of Medicine, Chapel Hill, NC;
  • Robert Irons, 3Division of Hematology-Oncology, Bone Marrow and Stem Cell Transplant Program, University of North Carolina School of Medicine, Chapel Hill, NC;
  • Amber Essenmacher, 3Division of Hematology-Oncology, Bone Marrow and Stem Cell Transplant Program, University of North Carolina School of Medicine, Chapel Hill, NC;
  • Thomas C. Shea, 3Division of Hematology-Oncology, Bone Marrow and Stem Cell Transplant Program, University of North Carolina School of Medicine, Chapel Hill, NC;
  • Kristy Richards, 1University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC; 7University of North Carolina Institute for Pharmacogenomics and Individualized Therapy, Chapel Hill, NC
  • Corey Cutler, 4Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, MA;
  • Jerome Ritz, 4Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, MA;
  • Jonathan Serody, 1University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC; 3Division of Hematology-Oncology, Bone Marrow and Stem Cell Transplant Program, University of North Carolina School of Medicine, Chapel Hill, NC;
  • Albert S. Baldwin, 1University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC;
  • Stefanie Sarantopoulos, 1University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC; 3Division of Hematology-Oncology, Bone Marrow and Stem Cell Transplant Program, University of North Carolina School of Medicine, Chapel Hill, NC;

Altmetric.com Statistics

The Altmetric score is a weighted count of online attention designed to reflect the volume and reach of online engagement surrounding an individual research output